Evaluation of 384‐well formatted sample preparation technologies for regulated bioanalysis
- 29 November 2006
- journal article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 21 (1) , 64-72
- https://doi.org/10.1002/rcm.2808
Abstract
The capabilities and limitations of 384‐well formatted sample preparation technologies applied to regulated bioanalysis were evaluated by developing two assays for the simultaneous quantitation of lopinavir and ritonavir, the active ingredients of Kaletra. One method used liquid‐liquid extraction (LLE), and the other used solid‐phase extraction (SPE). The steps and apparatuses employed by the two methods covered most of those used for bioanalysis. Briefly, the previously validated 96‐well formatted assays were adapted to the 384‐format with minor modifications. Because the wells of a 384‐well plate are clustered together, cross‐contamination between adjacent wells was evaluated critically, along with sensitivity, assay throughput, and ruggedness. Samples (35 µL) containing plasma samples (15 µL), internal standard (10 µL), and sodium carbonate (0.5 M, 10 µL to basify the sample) were placed in a 384‐well microtiter plate that may contain saquinavir or amprenavir as contamination markers. For LLE preparation, the samples were placed in a deep 384‐well plate (300‐µL well volume) and extracted with 150 µL of ethyl acetate. Approximately 50 µL of the extracts were removed from each well after phase separation for analysis. For SPE preparation, the fortified samples were transferred to a 384‐formatted SPE plate (C18, 5 mg packing). The extracts were eluted from the plate with basified 2‐propanol. The LLE or SPE extracts were dried and reconstituted for column‐switching high‐performance liquid chromatography with tandem mass spectrometric detection (HPLC/MS/MS). The lower limit of quantitation and the assay range were the same as the 96‐well formatted assay. If combined with appropriate automation, sample preparation in the 384‐well format would be up to five times more efficient than the 96‐well format. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 12 references indexed in Scilit:
- A novel approach for in‐process monitoring and managing cross‐contamination in a high‐throughput high‐performance liquid chromatography assay with tandem mass spectrometric detectionRapid Communications in Mass Spectrometry, 2006
- Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/mLJournal of Pharmaceutical and Biomedical Analysis, 2006
- Advantages of application of UPLC in pharmaceutical analysisTalanta, 2006
- Development of a High-Throughput Format for Solid-Phase Extraction of Enantiomers Using an Immunosorbent in 384-Well PlatesAnalytical Chemistry, 2005
- 96-Well solid-phase extraction: a brief history of its developmentJournal of Chromatography B, 2005
- Effect of temperature in reversed phase liquid chromatographyPublished by Elsevier ,2004
- A 384-Well Solid-Phase Extraction for LC/MS/MS Determination of Methotrexate and Its 7-Hydroxy Metabolite in Human Urine and PlasmaAnalytical Chemistry, 2000
- A clinical trial on a plate? The potential of 384-well format solid phase extraction for high-throughput bioanalysis using liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Rapid, Solid Phase Extraction Technique for the High-Throughput Assay of Darifenacin in Human PlasmaAnalytical Chemistry, 1996
- Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic StudiesPharmaceutical Research, 1992